Position in DXCM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,432,066
-$10,731,254 QoQ
Shares Held
118,345
-56.2% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Meridiem Capital Partners LP holds $181,543,188 across 6 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
858,921 | $77,697,993 | |
| 2 | ZBH |
Zimmer Biomet Holdings, Inc.
|
638,555 | $54,973,199 | |
| 3 | MDT |
Medtronic plc
|
431,042 | $33,720,415 | |
| 4 | ABT |
Abbott Laboratories
|
88,519 | $8,032,214 | |
| 5 | TNDM |
Tandem Diabetes Care Inc
|
298,255 | $4,500,667 | |
| 6 | PODD |
Insulet Corp
|
17,200 | $2,618,700 |
All Filings in DXCM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,432,066 | 118,345 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $18,163,320 | 269,926 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,052,014 | 195,349 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $32,157,739 | 413,498 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||